<DOC>
	<DOCNO>NCT01207583</DOCNO>
	<brief_summary>This study plan monitor local and/or systemic reaction compatibility PCV-7 routine vaccine Russian National immunization schedule . Consistent observational nature protocol , Prevenar administer standard care . The aim study estimate incidence febrile reaction 38.0 degree Celsius , specifically ( â‰¥38 &lt; 39 degree C ; &gt; 39 &lt; 40 degree C &gt; 40 degree C , frequency local systemic reaction follow vaccination Prevenar ( PCV-7 ) co-administered routine childhood vaccine condition routine daily use Russian Federation .</brief_summary>
	<brief_title>Prevenar ( PCV-7 ) Post-Licensure Safety Study In Russia</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Infants eligible Prevenar vaccination accord Regulatory approve term market authorization Russian Federation : Infants 3 month 23 month age may benefit active immunization disease cause Streptococcus pneumoniae serotypes 4 , 6B , 9V , 14 , 18C , 19F 23F ( include sepsis , meningitis , pneumonia , bacteraemia acute otitis medium ) . Parents legal guardian willing able complete diary card . Hypersensitivity active substance excipients ; Hypersensitivity diphtheria toxoid ; Age le 3 month great equal 2 year enrollment ; Contraindications list Package Insert / Russian SmPC either Prevenar concomitantly use vaccine ; Previously vaccinate 23valent pneumococcal polysaccharide vaccine ; Prophylactic use nonsteroidal antiinflammatory medication and/or acetaminophen ( e.g. , paracetamol ) . However , acetaminophen/paracetamol may administer treatment fever , pain , etc .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>vaccine</keyword>
	<keyword>infant</keyword>
	<keyword>healthy subject</keyword>
</DOC>